SCHEMBL5207077

SCHEMBL5207077

Nc1ncc(Cc2ccc(Cl)cc2Cl)c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
HTT P42858 3/20 0.47
LMNA P02545 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.43
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
PPP1CA P62136 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
IDO1 P14902 1/20 0.42
CA5A P35218 1/20 0.42
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
NR3C1 P04150 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
DAO P14920 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5209307 0.84 TYMS (0.36) SMN1; SMN2HTTL3MBTL1KDM4EALDH1A1
SCHEMBL5206921 0.81 PLA2G7 (0.49) DAO
SCHEMBL6049622 0.75 TYMS (0.44) LMNAKDM4EALDH1A1MAPTHPGD
SCHEMBL7716580 0.74 DAO (0.50) LMNAMAPTDAO
SCHEMBL7714354 0.72 PNP (0.51) NPC1
SCHEMBL2097653 0.72 IDO1 (0.65) SMN1; SMN2HTTLMNAL3MBTL1KDM4E
SCHEMBL3956905 0.72 SMN1; SMN2 (0.65) SMN1; SMN2HTTALDH1A1
SCHEMBL5206842 0.71 MEN1 (0.53) LMNAL3MBTL1ALDH1A1NPC1MAPT
SCHEMBL7515297 0.71 ITGB2 (0.50) ALDH1A1MAPTIDO1
SCHEMBL11542383 0.71 AOC3 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165523-B1 NEUROTROPHIC SUBSTITUTED PYRIMIDINES KRENITSKY PHARMACEUTICALS INC (US) 2007-11-07 EP disclosed
US-6916820-B1 Neurotrophic substituted pyrimidines KRENITSKY PHARMACEUTICALS, INC. (US) 2005-07-12 US disclosed
US-6583148-B1 Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine KRENITSKY PHARMACEUTICALS, INC. 2003-06-24 US disclosed